1 |
Ohno N, Miura NN, Nakajima M, Yadomae T. Antitumor 1,3-beta-glucan from cultured fruit body of Sparassis crispa. Biol Pharm Bull. 2000 ; 23(7) : 866-72.
DOI
|
2 |
Tada R, Harada T, Nagi-Miura N, Adachi Y, Nakajima M, Yadomae T, Ohno N. NMR characterization of the structure of a -(1 3)-D-glucan isolate from cultured fruit bodies of Sparassis crispa. Carbohydr Res. 2007 ; 342(17) : 2611-8.
DOI
|
3 |
Berit H. Falch, Terje Espevik, Liv Ryan, Bjorn T. Stokke. The cytokine stimulating activity of (1 3)- -D-glucans is dependent on the triple helix conformation. Carbohydrate Research. 2000 ; 329 : 587-96.
DOI
|
4 |
Taylor PR, Tsoni SV, Willment JA, Dennehy KM, Rosas M, Findon H, Haynes K, Steele C, Botto M, Gordon S, Brown GD. Dectin-1 is required for -glucan recognition and control of fungal infection. Nat Immunol. 2007 ; 8(1) : 31-8.
DOI
|
5 |
Saijo S, Fujikado N, Furuta T, Chung SH, Kotaki H, Seki K, Sudo K, Akira S, Adachi Y, Ohno N, Kinjo T, Nakamura K, Kawakami K, Iwakura Y. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nature Immunology. 2007 ; 8 : 39-46.
DOI
|
6 |
Shin HJ, Oh DS, Lee HD, Kang HB, Lee CW, Cha WS. Analysis of Mineral, Amino Acid and Vitamin Contents of Fruiting Body of Sparassis crispa. . J Life Science. 2007 ; 17(9) : 1290-93.
DOI
|
7 |
Yoshida H. Changes in carbohydrates and organic acids in the mycelium during vegetative growth of Sparassis crispa Wulf.: Fr. Japanese Society of Mushroom Science & Biotechnology. 2005 : 13(3) : 149-55.
|
8 |
Yoshida H. Hanabiratake mushroom [Sparassis crispa (Wulf.: Fr.)] chemical composition cultivated on sawdust substrate beds. apanese Society of Mushroom Science & Biotechnology. 2004 ; 12(4) : 157-63.
|
9 |
Bang S, Chae HS, Lee C, Choi HG, Ryu J, Li W, Lee H, Jeong GS, Chin YW, Shim SH. New Aromatic Compounds from the Fruiting Body of Sparassis crispa (Wulf.) and Their Inhibitory Activities on Proprotein Convertase Subtilisin/Kexin Type 9 mRNA Expression. J Agric Food Chem. 2017 ; 65(30) : 6152-57.
DOI
|
10 |
Kim MS, Lee KT, Jeon SM, Ka KH. The Quantities of Methyl Orsellinate and Sparassol of Sparassis latifolia by Host Plants. The Korean journal of mycology. 2013 ; 41(4) : 236-42.
DOI
|
11 |
Kimura T. Natural products and biological activity of the pharmacologically active cauliflower mushroom Sparassis crispa. Biomed Res Int. 2013 ; 9.
|
12 |
Woodward S, Sultan HY, Barrett DK, Pearce RB. "Two new antifungal metabolites produced by Sparassis crispa in culture and in decayed trees," Journal of General Microbiology. 1993 ; 139(1) : 153-59.
DOI
|
13 |
Kodani S, Hayashi K, Hashimoto M, Kimura T, Dombo M, Kawagishi H. New sesquiterpenoid from the mushroom Sparassis crispa. Biosci Biotechnol Biochem. 2009 ; 73(1) : 228-29.
DOI
|
14 |
Shibata A, Hida TH, Ishibashi K, Miura NN, Adachi Y, Ohno N. Disruption of actin cytoskeleton enhanced cytokine synthesis of splenocytes stimulated with beta-glucan from the cauliflower medicinal mushroom, Sparassis crispa Wulf.:Fr. (higher Basidiomycetes) in vitro. Int J Med Mushrooms. 2012 ; 14(3) : 257-69.
DOI
|
15 |
Harada T, Ohno N. Contribution of dectin-1 and granulocyte macrophage-colony stimulating factor (GM-CSF) to immunomodulating actions of betaglucan. Int Immunopharmacol. 2008 ; 8(4) : 556-66.
DOI
|
16 |
Harada T, Miura NN, Adachi Y, Nakajima M, Yadomae T, Ohno N. Granulocyte-macrophage colony-stimula- ting factor (GM-CSF) regulates cytokine induction by 1,3-beta-D-glucan SCG in DBA2 mice in vitro. J Interferon Cytokine Res. 2004 ; 24(8) : 478-89.
DOI
|
17 |
Cristina L, Harry J, Wichers, Huub F, Savelkoul J. Antiinflammatory and Immunomodulating Properties of Fungal Metabolites. Mediators of Inflammation. 2005 ; 2 : 63-80.
|
18 |
Hasegawa A, Yamada M, Dombo M, Fukushima R, Matsuura N, Sugitachi A. Sparassis crispa as biological response modifier. Gan To Kagaku Ryoho. 2004 ; 31(11) : 1761-3.
|
19 |
Yamamoto K, Kimura T, Sugitachi A, Matsuura N. Anti-angiogenic and anti-metastatic effects of beta-1,3-D-glucan purified from Hanabiratake, Sparassis crispa. Biol Pharm Bull. 2009 ; 32(2) : 259-63.
DOI
|
20 |
Nameda S, Harada T, Miura NN, Adachi Y, Yadomae T, Nakajima M, Ohno N. Enhanced cytokine synthesis of leukocytes by a beta-glucan preparation, SCG, extracted from a medicinal mushroom, Sparassis crispa. Immunopharmacol Immunotoxicol. 2003 ; 25(3) : 321-35.
DOI
|
21 |
Harada T, Kawaminami H, Miura NN, Adachi Y, Nakajima M, Yadomae T, Ohno N. Cell to cell contact through ICAM-1-LFA-1 and TNF-alpha synergistically contributes to GM-CSF and subsequent cytokine synthesis in DBA/2 mice induced by 1,3-beta-D-Glucan SCG. J Interferon Cytokine Res. 2006 ; 26(4) : 235-47.
DOI
|
22 |
Harada T, Miura NN, Adachi Y, Nakajima M, Yadomae T, Ohno N. IFN-gamma induction by SCG, 1,3-beta-D-glucan from Sparassis crispa, in DBA/2 mice in vitro. J Interferon Cytokine Res. 2002 ; 22(12) : 1227-39.
DOI
|
23 |
Harada T, Kawaminami H, Miura NN, Adachi Y, Nakajima M, Yadomae T, Ohno N. Mechanism of enhanced hematopoietic response by soluble beta-glucan SCG in cyclophosphamide - treated mice. Microbiol Immunol. 2006 ; 50(9) : 687-700.
DOI
|
24 |
Harada T, Miura N, Adachi Y, Nakajima M, Yadomae T, Ohn N. Effect of SCG, 1,3-beta-Dglucan from Sparassis crispa on the hematopoietic response in cyclophosphamide induced leukopenic mice. Biol Pharm Bull. 2002 ; 25(7) : 931-9.
DOI
|
25 |
Yoshitomi H, Iwaoka E, Kubo M, Shibata M, Gao M. Beneficial effect of Sparassis crispa on stroke through activation of Akt/eNOS pathway in brain of SHRSP. J Nat Med. 2011 ; 65(1) : 135-41.
DOI
|
26 |
Ko JH, Jeon WJ, Kwon HS, Yeon SW, Kang JH. Anti-obesity Effects of Ethanolic Extract of Polygonatum sibiricum Rhizome in High-fat Diet-fed Mice. Korean journal of food science and technology. 2015 ; 47(4) : 499-503.
DOI
|
27 |
Lee MR, Hou JG, Begum S, Wang YB, Oh DS, Wi AJ, Yoon BS, Sung CK. Anti-obesity Effects of Sparassis crispa on High-fat Diet-induced Obese Mice. Journal of Life Science 2014 ; 24 (9) : 952-58.
DOI
|
28 |
Lee MA, Park JK, Um MH, Jeon JW, Lee JM, Park YK. Lipolytic Effect of Sparassis crispa Extracts in Differentiated 3T3-L1 Cells and High Fat Diet-induced Obese Mice. Journal of the Korean Society of Food Science and Nutrition. 2012 ; 41(12) : 1708-15.
DOI
|
29 |
Hu S, Wang D, Zhang J, Du M, Cheng Y, Liu Y, Zhang N, Wang D, Wu Y. Mitochondria Related Pathway Is Essential for Polysaccharides Purified from Sparassis crispa Mediated Neuro-Protection against Glutamate- Induced Toxicity in Differentiated PC12 Cells. Int J Mol Sci. 2016 ; 17(2) : E133.
|
30 |
Choi JH, Lee HJ, Kim S. Purification and antithrombotic activity of wulfase, a fibrinolytic enzyme from the fruit bodies of the edible and medicinal mushroom Sparassis crispa Wulf. ex. Fr. Applied Biochemistry and Microbiology. 2016 ; 52(6) : 608-14.
DOI
|
31 |
Kim EJ, Yoo KH, Kim YS, Seok SJ, Kim JH. Biological Activities of Wild Sparassis crispa Extracts. The Korean journal of mycology. 2015 ; 43(1) : 40-46.
DOI
|
32 |
Jeong SY, Kang S, Hua CS, Ting Z, Park S. Synbiotic effects of -glucans from cauliflower mushroom and Lactobacillus fermentum on metabolic changes and gut microbiome in estrogen-deficient rats. Genes Nutr. 2017 ; 12 : 31.
DOI
|
33 |
Kimura T, Yamamoto K, Nishikaya Y. Comparison of the antitumor effect of the fruit body and the mycelia of Hanabiratake (Sparassis crispa). mushroom science and biotechnology. 2013 ; 21(3) : 129-32.
|
34 |
Ohno N, Nameda S, Harada T, Miura NN, Adachi Y, Nakajima M, Yoshida K, Yoshida H, Yadomae T. Immunomodulating activity of a -glucan preparation, SCG, extracted from a culinarymedicinal mushroom, Sparasis crispa Wulf.:Fr. (Aphyllophoromycetidae), and application to cancer patients. Int J Med Mushr. 2003 ; 5 : 373-81.
|
35 |
Yamamoto K, Nishikawa Y, Kimura T, Dombo M, Matsura N, Sugitachi A. Antitumor Activities of Low Molecular Weight Fraction Derived from the Cultured Fruit Body of Sparassis crispa in Tumor-Bearing Mice. Nippon Shokuhin Kagaku Kogaku Kaishi. 2007 ; 54(9) : 419-23.
DOI
|
36 |
Syojyo A, Nagatoshi F, Yamamoto R et. Immunomodulatory activity of the Lipids components in the fruit-body of Sparassis crispa. The Annual research report of Soai University. 2014 ; 30 : 15-20.
|
37 |
Masafumi Y, Kyosuke Y, Takashi K, Munehiko D. Effects of Hanabiratake (Sparassis crispa) on Allergic Rhinitis in OVA-Sensitized Mice. Food Science and Technology Research. 2008 ; 14(6) : 589-94.
DOI
|
38 |
Kim HH, Lee S, Singh TS, Choi JK, Shin TY, Kim SH. Sparassis crispa suppresses mast cell-mediated allergic inflammation: Role of calcium, mitogenactivated protein kinase and nuclear factor- B. Int J Mol Med. 2012 ; 30(2) : 344-50.
DOI
|
39 |
Kim EN, Roh SS, Jeong GS. Inhibitory Effect of Sparassis crispa (Wulf.) Extract on Monosodium Iodoacetate Induced Osteoarthritis. Korean Journal of Pharmacognosy. 2018 : 49 (3) : 262-69.
|
40 |
Han JM, Lee EK, Gong SY, Sohng JK, Kang YJ, Jung HJ. Sparassis crispa exerts anti - inflammatory activity via suppression of TLR-mediated NF- B and MAPK signaling pathways in LPS-induced RAW264.7 macrophage cells. J Ethnopharmacol. 2019 ; 231: 10-18.
DOI
|
41 |
Kim IK, Yun YC, Shin YC, Yoo JY. Effect of Sparassis crispa Extracts on Immune Cell Activation and Tumor Growth Inhibition. Journal of Life Science. 2013 ; 23(8) : 984-88.
DOI
|
42 |
Yan GH, Choi YH. Sparassis crispa Attenuates Carbon Tetrachloride- Induced Hepatic Injury in Rats. Korean J Phys Anthropol. 2014 ; 27(3) : 113-22.
DOI
|
43 |
Prasad R, Varshney VK, Harsh NS, Kumar M. Antioxidant Capacity and Total Phenolics Content of the Fruiting Bodies and Submerged Cultured Mycelia of Sixteen Higher Basidiomycetes Mushrooms from India. Int J Med Mushrooms. 2015 ; 17(10) : 933-41
DOI
|
44 |
Lee DS, Kim KH, Yook HS. Antioxidant Activities of Different Parts of Sparassis crispa Depending on Extraction Temperature. Korean journal of food science and technology. 2016 ; 45(11) : 1617-22.
|
45 |
Yamamoto K, Kimura T. Dietary Sparassis crispa (Hanabiratake) Ameliorates Plasma Levels of Adiponectin and Glucose in Type 2 Diabetic Mice. Journal of Health Science. 2010 ; 56(5) : 541-46.
DOI
|
46 |
Yamamoto K, Kimura T. Orally and topically administered Sparassis crispa (Hanabiratake) improved healing of skin wounds in mice with streptozotocin- induced diabetes. Biosci Biotechnol Biochem. 2013 ; 77(6) : 1303-5.
DOI
|
47 |
Kimura T, Hashimoto M, Yamada M, Nishikawa Y. Sparassis crispa (Hanabiratake) ameliorates skin conditions in rats and humans. Biosci Biotechnol Biochem. 2013 ; 77(9) : 1961-3.
DOI
|
48 |
Wasser SP, Weis AL. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms. a modern perspective. Crit Rev Immunol. 1999 ; 19(1) : 65-96.
|
49 |
Kwon AH, Qiu Z, Hashimoto M, Yamamoto K, Kimura T. Effects of medicinal mushroom (Sparassis crispa) on wound healing in streptozotocin - induced diabetic rats. Am J Surg. 2009 ; 197(4) : 503-9.
DOI
|
50 |
Takeyama A, Nagata Y, Shirouchi B, Nonaka C, Aoki H, Haraguchi T, Sato M, Tamaya K, Yamamoto H, Tanaka K. Dietary Sparassis crispa Reduces Body Fat Mass and Hepatic Lipid Levels by Enhancing Energy Expenditure and Suppressing Lipogenesis in Rats. J Oleo Sci. 2018 ; 67(9) : 1137-47.
DOI
|
51 |
Copot O, Tanase C. Maxent modelling of the potential distribution of ganoderma lucidum in north-eastern region of Romania. J Plant Dev. 2017 ; 24 : 133-144.
|
52 |
Novak M, Vetvicka V. -glucans history and the present ; Immunomodulatory aspects and mechanisms of action. Immunotoxicol. 2008 ; 5 : 47-57.
DOI
|
53 |
Chan GC, Chan WK, Sze DM. The effects of -glucan on human immune and cancer cells. J Hematol Oncol. 2009 ; 2 : 25.
DOI
|
54 |
Park HG, Shim YY, Choi SO, Park WM. New method development for nanoparticle extraction of water-soluble -(1 3)-D-glucan from edible mushrooms, Sparassis crispa and Phellinus linteus. J Agric Food Chem. 2009 ; 57 : 2147-54.
DOI
|
55 |
Nakajima M. Sparassis crispa -glucan 1.3. 1st ed. Seoul : Health Newspaper. 2014 : 19-20.
|
56 |
Kamae, Senji, Igarashi, Tsuneo. On the Brown Cubical Butt Rot of Larch, Firs and other Conifers Caused By Sprassis crispa (WULF.) FR. in Japan. Research Bulletins Of The College Experiment Forests Hokkaido University. 1959 ; 20(1) : 77-92.
|
57 |
Ka KH, Park WC, Yun GH, Oh DS, Cheon WJ, Park JM. Sparassis crispa. National Institute of Forest Science. 2007 ; 295 : 13-15.
|
58 |
Harada T, Nagi Miura N, Adachi Y, Nakajima M, Yadomae T, Ohno N. Antibody to soluble 1,3/1,6-beta-D-glucan, SCG in sera of naive DBA/2 mice. Biol Pharm Bull. 2000 ; 26(8) : 1225-8.
DOI
|
59 |
Kim MY, Seguin P, Ahn JK, Kim JJ, Chun SC, Kim EH, Seo SH, Kang EY, Kim SL, Park YJ, Ro HM, Chung IM. Phenolic Compound Concentration and Antioxidant Activities of Edible and Medicinal Mushrooms from Korea. J, Agric Food Chem. 2008 ; 56(16) : 7265-70.
DOI
|
60 |
Kiyama R, Furutani Y, Kawaguchi K, Nakanishi T. Genome sequence of the cauliflower mushroom Sparassis crispa (Hanabiratake) and its association with beneficial usage. Sci Rep. 2018 ; 8(1) : 16-53.
DOI
|
61 |
Yoshikawa K, Kokudo N, Hashimoto T, Yamamoto K, Inose T, Kimura T. Novel phthalide compounds from Sparassis crispa (Hanabiratake), Hanabiratakelide A-C, exhibiting anti-cancer related activity. Biol Pharm Bull. 2010 ; 33(8) : 1355-9.
DOI
|
62 |
Tada R, Adachi Y, Ohno N. A concise method using nuclear magnetic resonance spectroscopy to determine the source of the -glucan extracted from various mushrooms. Int J Med Mushrooms. 2012 ; 14(4) : 339-45.
DOI
|